产品编号 :
Cas No. :
CAS No. |
183721-15-5 |
|---|---|
中文名称 |
N-(9-氯-2-(呋喃-2-基)-[1,2,4]三唑并[1,5-c]喹唑啉-5-基)-2-苯基乙酰胺 |
英文名称 |
N-(9-Chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)-2-phenylacetamide |
别名 |
HMS3676O15 | 9-CHLORO-2-(2-FURANYL)-5-[(PHENYLACETY)AMINO][1,2,4]-TRIAZOLO[1,5-C] QUINAZOLINE | MRS 1220, solid | N-[9-Chloro-2-(2-furanyl)[1,2,4]-triazolo[1,5-c]quinazolin-5-yl]benzene acetamide | Q27087759 | HY-103190 | AKOS024456471 | GTPL448 | Benzene |
标准英文名 |
N-(9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)-2-phenylacetamide |
分子式 |
C21H14ClN5O2 |
分子量 |
403.83 |
精确分子量 |
403.08 |
SMILES |
O=C(NC1=NC2=C(C=C(Cl)C=C2)C3=NC(C4=CC=CO4)=NN13)CC5=CC=CC=C5 |
标准SMILES |
O=C(CC1C=CC=CC=1)NC1=NC2C=CC(Cl)=CC=2C2=NC(=NN21)C1=CC=CO1 |
用途 |
MRS1220 is a potent and selective human A3 adenosine receptor (hA3AR) antagonist (Ki = 0.59 nM), used in the research of central nervous system disorders; it also reduces glioblastoma tumor size and angiogenesis in vivo. |
InChIKey |
TWWFAXQOKNBUCR-UHFFFAOYSA-N |
|
|
评论 |
|---|